Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move
across top level links and expand / close menus in sub levels. Up and Down arrows will open main level
menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab
will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Join the brightest minds in regulatory at the annual Regulatory Convergence. See the global regulatory community in action. Intensive workshops. Topical sessions. Meet ups with regulators. This is where it all comes together.
For 20 years, our flagship publication, Fundamentals of US Regulatory Affairs, has been giving regulatory professionals the insights and answers they need, right at their fingertips.
There are hundreds of RAC testing centers available worldwide. Any of the four RAC exams (US, EU, CAN or Global) may be taken at any location. Find an upcoming exam at a location near you.
Posted 25 May 2012 | By Alexander Gaffney, RAC
The European Medicines Agency (EMA) is moving quickly to implement the International Conference on Harmonization's (ICH) Quality (Q) 11 guidance, saying it has adopted the standard and plans to implement it by the end of 2012.
The guidance pertains to the drug development process and describes information necessary for inclusion in the Common Technical Document (CTD). The guidance also clarifies existing guidance, including its Q8, Q9 and Q10 guidance documents.
ICH released the Q11: Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological Biological Entities guidance on 11 May 2012, and said it was simultaneously moving to notify ICH signatory countries so they could implement the guidance. ICH members include the US, EU and Japan.
EMA said its Committee for Medicinal Products for Human Use (CHMP) had adopted the Q11 proposal in May 2012, and the guidance will come into effect in the EU in November 2012.
ICH guideline Q11 on development and manufacture of drug substances (chemical entities and biotechnological/biological entities)
Regulatory Focus - ICH Finishes Q11 Quality Manufacturing Guideline, Prepares to Notify Regulators
Tags: Q11, Latest News, guidance
Regulatory Focus newsletters
All the biggest regulatory news and happenings.